PLASMA FRACTIONATION MARKET ANALYSIS

Market News

Key Developments:

• In September 2019, Biopharma, a Ukraine based company which is specialized for the production of plasma-based, recombinant and other drugs, launched a new plant for plasma fractionation in Bila Tserkva, Ukraine. The company offers a unique plasma fractionation technology which allows the plasma components of the blood to be processed for the extraction of life-saving drugs and the company is equipped with GMP – certified equipments and facilities. The launch of the company has put Ukraine almost on the same page as that of USA, Austria, and Germany. In the facility, production of blood products like Albumin, Bioven and Immunoglobulin is expected to help treat diseases caused due to immunodeficiency.
• In June 2019, Egypt initiated a project for the setup of the blood plasma fractionations and processing plant in the country in order to establish labs for the plasmapheresis.
• In 2017, Green Cross Biotherapeutics launched a new plasma fractionation plant in Technoparc, Montreal. The Quebech governmmet granted US$ 21.4 million for the project.
• In 2017, Probitas Foundation in collaboration with Grifols, S.A, encouraged plasma donations from the Ebola survivors in order to produce immunity against Ebola. In order to process plasma donations form the Ebola survivors, Grifols S.A. set up a plasmapheresis plant in